广告
加载中

京东健康与鱼跃医疗聚焦“AI+医疗器械”:计划三年内售出1500万台

亿邦动力 2026-07-03 16:13
亿邦动力 2026/07/03 16:13

邦小白快读

EN
全文速览

本文核心是京东健康与鱼跃医疗升级AI+医疗器械领域战略合作,推出了面向普通用户的新服务,核心干货如下:

1.本次合作推出“三年1500万台智能健康互联计划”,双方早在今年3月就定下三年100亿销售额的目标,上半年合作已经取得突出成果,血糖、心电、制氧等品类增长显著,部分产品同比增长超过200%,还新增了20款京东专供产品,产品供给更丰富。

2.普通用户可以获得更完善的家庭健康管理服务,后续鱼跃的智能健康设备将直连京东健康APP,你可以方便记录、管理血压、血糖等健康指标,还能获得智能健康提醒和管理建议;呼吸机等设备会打通在线问诊、设备指导、随访管理等全环节,在家就能享受完整的健康管理服务。

本文呈现了医疗器械品牌和互联网健康平台合作的成功案例,能给品牌发展提供诸多参考,核心干货如下:

1.合作模式验证,鱼跃和京东健康的合作中,上半年多个核心品类实现爆发式增长,CGM动态血糖仪、心电检测仪同比增长超200%,通过京东专供包销模式,上半年新增20款专供产品,既实现了差异化供给,又带来了销量增长,该模式具备可复制性。

2.方向参考,当前家庭健康管理场景需求持续上涨,品牌可以锚定AI+医疗器械的升级方向,绑定头部互联网健康平台的流量和服务能力,打通从设备销售到健康服务的全链路,既能获得规模化的销量增长,也能提升品牌的用户粘性,本次双方定下的三年百亿销售额、千万台销量的目标,也给同类品牌做目标规划提供了参考。

本文透露了线上医疗器械品类的新增长机会,给卖家带来多方面的参考,核心干货如下:

1.赛道机会,当前AI+智能医疗器械正处于高速增长期,家庭健康管理场景下的血糖管理、心电监测、呼吸制氧等细分品类需求旺盛,头部品牌合作下相关品类已经实现翻倍以上的增长,是极具潜力的增量赛道,值得卖家提前布局。

2.经营参考,卖家可以学习本次合作中的专供包销模式,和大平台合作开发专供产品,做差异化供给,有效避开同质化价格竞争;同时可以依托平台的健康服务体系,给产品延伸配套健康服务,提升产品的附加值,也能增强用户的复购粘性,卖家要抓住AI技术和家庭健康需求结合的风口,抓住新一波增长红利。

本文给医疗器械生产工厂带来了产品方向和数字化转型的启示,核心干货如下:

1.产品生产设计方向,当前市场对AI化、智能互联的家庭医疗器械需求旺盛,血糖管理、心电监测、呼吸制氧等面向家庭健康场景的产品增长速度极快,工厂可以围绕家庭健康管理的使用场景,调整产品研发设计方向,重点开发支持智能互联、数据上传的AI化产品,适配市场需求。

2.商业机会与转型启示,工厂可以主动对接京东健康这类头部大健康平台,探索专供包销的合作模式,依托平台的用户数据更精准地匹配消费需求;还可以通过数据直连接入平台的服务体系,把单纯的设备生产销售延伸到后续健康管理服务链路,提升产品的附加价值,同时也能借助平台的资源推进自身的数字化转型,打开更大的销量增长空间。

本文反映了AI+医疗器械领域的行业新趋势,也明确了市场的需求方向,给服务商带来诸多参考,核心干货如下:

1.行业发展趋势,当前AI+医疗器械是大健康领域的核心增长方向,用户的需求已经从单纯购买医疗器械,转向购买包含设备、数据管理、问诊随访在内的完整健康管理方案,产业的服务化转型趋势明显,给服务商带来了全新的市场空间。

2.客户需求与业务方向,现在医疗器械品牌需要完成数字化升级,打通设备、数据和服务的全链路,互联网健康平台需要丰富优质的智能设备供给,完善自身的服务生态,服务商可以围绕AI设备互联、用户数据直连、全链路健康服务整合这些方向,开发适配品牌和平台需求的解决方案,对接行业痛点,获得新的业务增长机会。

本文展现了健康平台和医疗器械品牌合作的创新模式,给平台的运营招商带来参考,核心干货如下:

1.品牌合作需求,当前传统医疗器械品牌有拓展线上销量、完成数字化升级、延伸服务链路的强烈需求,平台可以依托自身的流量优势、用户体系、互联网医院资源,和品牌开展深度战略合作,打造平台+品牌的共赢生态,既丰富平台的产品供给,也能提升平台的服务能力。

2.运营与招商参考,平台可以大力推进专供包销品的合作模式,吸引品牌开发平台专属产品,丰富平台的差异化供给,满足用户的个性化需求;同时可以重点布局AI+医疗器械智能互联生态,吸引头部品牌入驻合作,打造标杆案例,再依托标杆吸引更多同类品牌加入,扩大平台生态规模,还能通过全链路健康服务的打造,提升平台用户的粘性,增强平台的核心竞争力。

本文记录了大健康领域的产业新动向,呈现了创新合作模式,给产业研究提供了鲜活样本,核心干货如下:

1.产业新动向,当前国内大健康产业正加速向智能化、服务化方向转型,家庭健康管理赛道已经进入高速增长阶段,互联网健康平台和上游医疗器械品牌的合作,已经从早期简单的流量销售合作,转向全链路、全生态的深度绑定,产业融合的深度比以往大幅提升,这是大健康产业升级的新趋势。

2.商业模式研究,本次合作推出的三年千万台智能互联计划,整合了专供包销、数据直连、全链路服务整合等多种模式,把传统的一次性设备销售,转化为覆盖用户全周期的健康管理服务,验证了互联网平台改造传统医疗器械产业的可行性,为研究传统制造业和互联网平台融合升级提供了新的样本,也展现了大健康产业未来的发展方向。

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

This article focuses on JD Health and Yuwell Medical’s expanded strategic partnership in the AI+medical devices sector, which has launched new services for general consumers. Key takeaways are as follows:

1. The partnership launched a "3-year 15 million connected smart health devices initiative". The two parties set a 10 billion yuan sales target for three years back in March this year, and the collaboration already delivered strong results in the first half of 2024. Categories including blood glucose monitoring, ECG monitoring and oxygen concentrators saw robust growth, with some products posting year-over-year growth exceeding 200%. The partners also added 20 new JD-exclusive products to expand product offerings.

2. Consumers will gain access to more comprehensive home health management services. Moving forward, Yuwell’s smart health devices will connect directly to the JD Health app, allowing users to conveniently record and track health metrics including blood pressure and blood glucose, receive smart health reminders and personalized management advice. For products like ventilators, the partnership will integrate end-to-end services including online consultation, device guidance and follow-up management, enabling users to access complete health management services from home.

This article presents a successful case of collaboration between a medical device brand and an internet health platform, offering key insights for brand development. Key takeaways are as follows:

1. The partnership model has been validated. In the first half of the year, multiple core categories from Yuwell delivered explosive growth: continuous glucose monitors (CGM) and ECG monitors saw year-over-year growth exceeding 200%. Through the JD-exclusive underwriting sales model, Yuwell launched 20 new exclusive products in the first half, achieving differentiated product offerings while driving sales growth, making this model replicable for other brands.

2. It provides strategic direction. Against rising consumer demand for home health management, brands can anchor their upgrade in the AI+medical device direction, partner with leading internet health platforms to leverage their traffic and service capabilities, and build an end-to-end ecosystem from device sales to ongoing health services. This enables both scalable sales growth and improved user retention. The 10 billion yuan 3-year sales target and 15 million unit sales goal set by the two partners also serve as a useful reference for peer brands in strategic planning.

This article reveals new growth opportunities for online medical device categories, offering multi-dimensional insights for sellers. Key takeaways are as follows:

1. It identifies a high-potential growth track. AI-powered smart medical devices are currently in a period of rapid growth, with strong demand for niche categories such as blood glucose management, ECG monitoring and respiratory oxygen therapy in the home health scenario. The leading brands’ collaboration has already delivered more than 100% growth for relevant categories, making this a high-potential incremental track worth early布局 by sellers.

2. It offers operational guidance. Sellers can learn from the exclusive underwriting model used in this collaboration: develop platform-exclusive products in partnership with large platforms to deliver differentiated offerings and effectively avoid homogenized price competition. At the same time, sellers can extend supporting health services for their products based on the platform’s existing health service system, boost product added value, and improve user repeat purchase and retention. Sellers should capitalize on the trend combining AI technology and rising home health demand to capture the next wave of growth dividends.

This article offers insights on product direction and digital transformation for medical device manufacturing factories. Key takeaways are as follows:

1. It guides product R&D and design direction. There is currently strong market demand for AI-powered, connected home medical devices, and home health-focused products such as blood glucose management devices, ECG monitors and respiratory oxygen equipment are growing extremely fast. Factories can adjust their R&D and design focus around home health management scenarios, prioritizing development of AI-enabled products that support smart connectivity and data uploading to align with market demand.

2. It reveals new business opportunities and transformation insights. Factories can proactively partner with leading big health platforms like JD Health to explore the exclusive underwriting collaboration model, and leverage the platform’s user data to match consumer demand more accurately. They can also connect their device data directly to the platform’s service system, extending their business from pure device manufacturing and sales to the full downstream health management service chain to boost product added value, while leveraging platform resources to advance their own digital transformation and unlock greater sales growth.

This article reflects new industry trends in the AI+medical device sector and clarifies market demand direction, offering key insights for service providers. Key takeaways are as follows:

1. It outlines core industry development trends. AI+medical devices is currently the core growth direction in the big health industry. Consumer demand has shifted from simply purchasing medical devices to purchasing complete health management solutions that integrate devices, data management, consultation and follow-up, driving a clear industry trend toward service-oriented transformation that opens up entirely new market opportunities for service providers.

2. It clarifies client demand and business direction. Today, medical device brands need to complete digital upgrades and build an end-to-end connected ecosystem of devices, data and services, while internet health platforms need high-quality smart device supply to enrich their service ecosystems. Service providers can develop solutions aligned with the needs of both brands and platforms around AI device connectivity, direct user data integration, and end-to-end health service integration, addressing industry pain points to capture new business growth opportunities.

This article presents an innovative collaboration model between health platforms and medical device brands, offering insights for platform operation and merchant recruitment. Key takeaways are as follows:

1. It clarifies brand collaboration demand. Traditional medical device brands currently have strong demand to expand online sales, complete digital upgrades, and extend their service chains. Platforms can leverage their own advantages in traffic, user ecosystems, and internet hospital resources to build deep strategic partnerships with brands, creating a win-win platform-brand ecosystem that enriches the platform’s product supply and improves its service capabilities.

2. It offers operational and recruitment guidance. Platforms can actively promote the exclusive underwriting collaboration model to attract brands to develop platform-exclusive products, enrich differentiated supply and meet personalized consumer demand. At the same time, platforms can prioritize building an AI+smart connected medical device ecosystem, attract leading brands to collaborate to build benchmark cases, then leverage these benchmarks to attract more peer brands and expand the platform ecosystem scale. Building end-to-end health services also improves user retention and strengthens the platform’s core competitiveness.

This article documents new industry developments in the big health sector and presents an innovative collaboration model, providing a fresh case study for industrial research. Key takeaways are as follows:

1. It highlights new industry trends. China’s big health industry is currently accelerating its shift toward intelligence and service-orientation, and the home health management track has entered a phase of rapid growth. Collaboration between internet health platforms and upstream medical device brands has evolved from early, simple traffic-based sales partnerships to deep, end-to-end, ecosystem-wide binding. The depth of industrial integration has increased substantially compared to previous eras, representing a new trend in big health industry upgrading.

2. It advances business model research. The 3-year 15 million smart connected devices initiative launched through this partnership integrates multiple models including exclusive underwriting, direct data connection, and end-to-end service integration. It transforms traditional one-time device sales into full-lifecycle health management services for users, validating the feasibility of internet platforms transforming the traditional medical device industry. This provides a new case study for research on the integration and upgrading of traditional manufacturing and internet platforms, and also illustrates the future development direction of the big health industry.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

【亿邦原创】7月2日,京东健康与鱼跃医疗宣布在“AI+医疗器械”领域达成新一轮战略合作升级。双方基于上半年在核心品类高速增长、专供品开发及新品首发等方面取得的显著成果,正式启动“三年1500万台智能健康互联计划”。进一步推动AI医疗器械接入京东健康APP与HomeCare服务体系,实现从设备连接、数据管理到健康服务的全链路升级。

据悉,双方自今年3月确立全面战略合作关系、锚定“三年100亿销售目标”。京东健康的数据显示,上半年,双方合作成果持续显现,在血糖管理、心电监测、呼吸制氧等多个核心品类实现显著增长。其中,鱼跃CGM动态血糖仪、心电检测仪同比增长超过200%,成为京东健康医疗器械业务中的高增长品类。在专供品合作方面,双方上半年新增20款京东专供包销品,围绕家庭健康管理场景持续丰富差异化供给。

下半年,双方将通过数据直连京东健康APP,帮助用户便捷记录、查看和管理血压、血糖等关键健康指标,并基于连续数据提供更智能的健康提醒与管理建议。在呼吸治疗场景中,鱼跃呼吸机将进一步接入京东互联网医院与HomeCare服务体系,打通在线问诊、设备指导、数据解读、随访管理等环节,为用户提供覆盖“监测—解读—干预—随访”的全链路健康管理服务。

根据规划,未来三年内,鱼跃医疗将成为京东健康“AI+医疗器械”智能互联生态中设备直连量级最大、品类覆盖最广、服务深度最深的品牌合作伙伴。

亿邦持续追踪报道该情报,如想了解更多与本文相关信息,请扫码关注作者微信。

文章来源:亿邦动力

广告
微信
朋友圈

FAQ回顾

京东健康和鱼跃医疗在AI医疗器械领域有什么合作规划?

双方已启动三年1500万台智能健康互联计划,锚定三年100亿销售目标,将推动AI医疗器械接入京东健康APP与HomeCare服务体系,实现设备连接、数据管理到健康服务的全链路升级。

京东健康与鱼跃医疗上半年合作取得了哪些成果?

上半年双方在血糖管理、心电监测、呼吸制氧等核心品类实现显著增长,鱼跃CGM动态血糖仪、心电检测仪同比增长超200%,还新增20款京东专供包销品,丰富家庭健康管理场景差异化供给。

AI医疗器械接入京东健康体系能为用户带来什么服务?

用户可便捷记录、查看和管理血压、血糖等关键健康指标,获得智能健康提醒与管理建议;呼吸治疗场景可享受覆盖监测、解读、干预、随访的全链路健康管理服务。

这么好看,分享一下?

朋友圈 分享

APP内打开

+1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0